Spero Therapeutics
SPRO
#9017
Rank
HK$0.55 B
Marketcap
HK$10.26
Share price
0.76%
Change (1 day)
18.38%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of June 2024 : HK$0.49 Billion

According to Spero Therapeutics's latest financial reports the company has HK$0.49 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.59 B-30.07%
2022-12-31HK$0.85 B-25.32%
2021-12-31HK$1.14 B16.04%
2020-12-31HK$0.98 B53.97%
2019-12-31HK$0.63 B-29.32%
2018-12-31HK$0.90 B32.56%
2017-12-31HK$0.68 B752.6%
2016-12-31HK$79.98 M81.34%
2015-12-31HK$44.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$0.28 B-42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$106.51 B 21,468.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$13.87 B 2,709.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada